Yang Bing, Xu Yan, Zhang Weiye, Zhu Dandan, Huang Bin, Yang Yanjun, Jia Xiaobin, Feng Liang
School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China; Jiangning Hospital of Chinese Medicine, China Pharmaceutical University, Nanjing 211198, PR China.
School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.
Int J Biol Macromol. 2025 May;310(Pt 2):143184. doi: 10.1016/j.ijbiomac.2025.143184. Epub 2025 Apr 18.
Polysaccharides have garnered increasing attention in recent years for their potential in oral drug delivery within biomaterials and pharmaceuticals, owing to their excellent physicochemical properties, bioactivity, and low toxicity. However, the absorption of polysaccharides encounters multiple challenges posed by the biological, chemical, mechanical, and immune barriers of the intestinal mucosa. Therefore, elucidating the mechanisms by which polysaccharides traverse the intestinal mucosa for oral absorption is essential for their further development and application. Current studies have identified several polysaccharide absorption pathways, including transcellular transport, paracellular transport, M cell and Peyer's patches mediated transport, and intestinal flora mediated transport. Furthermore, numerous studies have demonstrated that polysaccharides can enhance the solubility, gastrointestinal stability, and permeability of small molecule components, which significantly improves their bioavailability. More importantly, nano-delivery systems utilizing polysaccharides as carriers have shown great promise in enhancing the targeting of small molecule components, thereby opening new avenues for drug delivery applications. We hope this review will provide theoretical support and inspiration for a deeper understanding of oral absorption mechanisms and the potential of polysaccharides in the development of nano-delivery systems.
近年来,多糖因其在生物材料和药物领域口服给药方面的潜力而受到越来越多的关注,这归因于其优异的物理化学性质、生物活性和低毒性。然而,多糖的吸收面临着肠道黏膜的生物、化学、机械和免疫屏障带来的多重挑战。因此,阐明多糖穿过肠道黏膜进行口服吸收的机制对于其进一步的开发和应用至关重要。目前的研究已经确定了几种多糖吸收途径,包括跨细胞转运、细胞旁转运、M细胞和派尔集合淋巴结介导的转运以及肠道菌群介导的转运。此外,大量研究表明,多糖可以提高小分子成分的溶解度、胃肠道稳定性和渗透性,这显著提高了它们的生物利用度。更重要的是,以多糖为载体的纳米递送系统在增强小分子成分的靶向性方面显示出巨大的潜力,从而为药物递送应用开辟了新途径。我们希望这篇综述将为更深入理解口服吸收机制以及多糖在纳米递送系统开发中的潜力提供理论支持和启发。